MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 4, Pages 785-796
Publisher
Informa UK Limited
Online
2012-02-22
DOI
10.4161/cc.11.4.19228
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway
- (2011) N. M. Alajez et al. CANCER RESEARCH
- MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
- (2011) J. Lu et al. CANCER RESEARCH
- MicroRNAs as regulators of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. CELL CYCLE
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells
- (2011) Linda S. Steelman et al. CELL CYCLE
- 14-3-3 Exerts Tumor-Suppressor Activity Mediated by Regulation of COP1 Stability
- (2010) C.-H. Su et al. CANCER RESEARCH
- Identification of Biomarkers for Predicting Nasopharyngeal Carcinoma Response to Radiotherapy by Proteomics
- (2010) Xue-Ping Feng et al. CANCER RESEARCH
- microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network
- (2010) Liming Zhang et al. CARCINOGENESIS
- PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation
- (2010) J-J Lee et al. CELL DEATH AND DIFFERENTIATION
- MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells
- (2010) X. Qin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1
- (2009) Heesang Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C
- (2009) P. Gandellini et al. CANCER RESEARCH
- Suppression of cell growth and invasion by miR-205 in breast cancer
- (2009) Hailong Wu et al. CELL RESEARCH
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells
- (2008) Li Qin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of PTEN and γ-Ionizing Radiation Enhances Cell Death and G2/M Arrest Through Regulation of AKT Activity and p21 Induction in Non–Small-Cell Lung Cancer Cells
- (2008) Jong Kuk Park et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- MicroRNA in Cancer Prognosis
- (2008) Frank J. Slack et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins
- (2008) S. Sengupta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started